TNF and migraine disorder: Mechanistically, Mt2 regulates cerebrovascular compliance via modulating the release of migraine‐associated mediators (CGRP, IL‐6, TNF‐α), thereby establishing an interface between vascular tone dysregulation and migraine‐like pain thresholds.